Deirdre Geraghty | A&L Goodbody LLP| New York

Europe

  • Dublin
  • Belfast
  • London

United States

  • New York
  • San Francisco
  • Palo Alto
See all Close
Skip to content A&L Goodbody Logo
  • People
  • Services
  • Careers
  • Offices

Home

  • People
  • Services
  • Insights
  • International
  • Knowledge
  • ALG Solutions
  • Responsible Business
  • News
  • Awards
  • About Us
  • Contact Us

Careers

Offices

  • Dublin
  • Belfast
  • London
  • New York
  • San Francisco
  • Palo Alto
  • Print
  • Share
    • Linked In
    • Twitter
Deirdre Geraghty - New York
Deirdre Geraghty,

Deirdre Geraghty

Partner, Corporate and M&A

New York

t:
+353 1 649 2573
e:
dgeraghty@algoodbody.com
Add to contacts
  • Home
  • People
  • Deirdre Geraghty

Deirdre Geraghty is a Partner in the firm's Corporate and M&A Group and is based in our New York office. She has extensive experience advising international and domestic clients on all aspects of corporate law including public and private M&A, equity capital markets, corporate restructurings and corporate governance. Deirdre advises clients across a range of industry sectors including pharma/healthcare, technology and energy. She also frequently advises US companies who are establishing operations in Ireland for the first time, having spent a number of years in the firm's New York office. 

Areas of Expertise
Corporate and M&A/Capital Markets – Equity/PLC Advisory & Governance/Investing in Ireland/Corporate Advisory & Company Law/Corporate migrations to Ireland and de-SPAC M&A
Experience Advising:
  • ESB on its strategic renewable energy joint venture with Coillte, FuturEnergy Ireland
  • IPS-Integrated Project Services, a portfolio company of Alleghany Capital, on its acquisition of Linesight
  • Iterum Therapeutics plc on its $52m convertible debt financing
  • Morgan Stanley, as AbbVie Inc’s lead financial advisor and lender, in connection with AbbVie’s $63bn acquisition of Allergan plc
  • Osmotica Pharmaceuticals plc on its IPO on NASDAQ
  • Iterum Therapeutics plc on its IPO on NASDAQ
  • Adient plc on its $5bn spin-off from Johnson Controls plc
  • Johnson Controls Inc. on its $20bn merger with Tyco plc
  • Medtronic, Inc. on its $49bn acquisition of Covidien plc in January 2015 (Global M&A Deal of the Year 2015: Ireland - American Lawyer)
Education
  • Solicitor, Law Society of Ireland
  • MSc in the Business of Law, UCD Smurfit Graduate Business School
  • BBLS, University College Dublin
Deirdre Geraghty - New York

Deirdre Geraghty

Partner, Corporate and M&A
New York

t:
+353 1 649 2573
e:
dgeraghty@algoodbody.com
Add to contacts
  • Home
  • People
  • Services
  • Careers
  • Insights
  • International
  • Knowledge
  • Responsible Business
  • News
  • Awards
  • About Us
  • Contact Us
  • Privacy
  • Legal Notices
  • Cookie Policy
  • Manage Cookies
  • Accessibility
    • Linked In
    • Twitter
    • Youtube
    • 律所簡介

©2022 A&L Goodbody LLP. All rights reserved.